Afroditi Nonni

1.2k total citations
49 papers, 879 citations indexed

About

Afroditi Nonni is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Afroditi Nonni has authored 49 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 20 papers in Pathology and Forensic Medicine and 20 papers in Oncology. Recurrent topics in Afroditi Nonni's work include Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (13 papers) and Cancer Cells and Metastasis (8 papers). Afroditi Nonni is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (13 papers) and Cancer Cells and Metastasis (8 papers). Afroditi Nonni collaborates with scholars based in Greece, United States and Switzerland. Afroditi Nonni's co-authors include Konstantinos Kontzoglou, George Zografos, Flora Zagouri, Efstratios Patsouris, Christos Damaskos, Nikolaos Garmpis, Dimitrios Dimitroulis, Anna Garmpi, Theodoros Ν. Sergentanis and Dimitra Koulocheri and has published in prestigious journals such as Current Medicinal Chemistry, Oncotarget and Breast Cancer Research and Treatment.

In The Last Decade

Afroditi Nonni

48 papers receiving 862 citations

Peers

Afroditi Nonni
Francisco Beça United States
Alessandro Bombonati United States
Nazeel Ahmad United States
Ardeshir Hakam United States
Angel Rodriguez United States
Francisco Beça United States
Afroditi Nonni
Citations per year, relative to Afroditi Nonni Afroditi Nonni (= 1×) peers Francisco Beça

Countries citing papers authored by Afroditi Nonni

Since Specialization
Citations

This map shows the geographic impact of Afroditi Nonni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afroditi Nonni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afroditi Nonni more than expected).

Fields of papers citing papers by Afroditi Nonni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afroditi Nonni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afroditi Nonni. The network helps show where Afroditi Nonni may publish in the future.

Co-authorship network of co-authors of Afroditi Nonni

This figure shows the co-authorship network connecting the top 25 collaborators of Afroditi Nonni. A scholar is included among the top collaborators of Afroditi Nonni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afroditi Nonni. Afroditi Nonni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Psilopatis, Iason, Nikolaos Garmpis, Anna Garmpi, et al.. (2023). The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy. Cancers. 15(8). 2222–2222. 18 indexed citations
3.
Garmpis, Nikolaos, Christos Damaskos, Anna Garmpi, et al.. (2021). Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities. Journal of Personalized Medicine. 11(3). 223–223. 26 indexed citations
4.
Damaskos, Christos, Nikolaos Garmpis, Anna Garmpi, et al.. (2021). Investigational Drug Treatments for Triple-Negative Breast Cancer. Journal of Personalized Medicine. 11(7). 652–652. 14 indexed citations
5.
Chatziandreou, Ilenia, et al.. (2021). mRNA coexpression patterns of Wnt pathway components and their clinicopathological associations in breast and colorectal cancer. Pathology - Research and Practice. 227. 153649–153649. 4 indexed citations
6.
Tampakis, Athanasios, Ekaterini Christina Tampaki, Afroditi Nonni, et al.. (2021). MAP17 Expression in Colorectal Cancer Is a Prognostic Factor for Disease Recurrence and Dismal Prognosis Already in Early Stage Disease. Oncology. 99(7). 471–482. 3 indexed citations
7.
Vagios, Stylianos, Elpida Giannikaki, Christos Papadimitriou, et al.. (2019). The impact of programmed cell death-ligand 1 (PD-L1) and CD8 expression in grade 3 endometrial carcinomas. International Journal of Clinical Oncology. 24(11). 1419–1428. 16 indexed citations
8.
Tampakis, Athanasios, Ekaterini Christina Tampaki, Afroditi Nonni, et al.. (2019). Nectin-1 Expression in Colorectal Cancer: Is There a Group of Patients with High Risk for Early Disease Recurrence?. Oncology. 96(6). 318–325. 8 indexed citations
9.
Tampaki, Ekaterini Christina, Athanasios Tampakis, Afroditi Nonni, et al.. (2019). Combined Fascin-1 and MAP17 Expression in Breast Cancer Identifies Patients with High Risk for Disease Recurrence. Molecular Diagnosis & Therapy. 23(5). 635–644. 13 indexed citations
10.
Sergentanis, Theodoros Ν., Konstantinos Kontzoglou, Efstratios Patsouris, et al.. (2018). The Prognostic Significance of Hsp70/Hsp90 Expression in Breast Cancer: A Systematic Review and Meta-analysis. Anticancer Research. 38(3). 1551–1562. 49 indexed citations
11.
Kostakis, Ioannis D., Christos Damaskos, Nikolaos Garmpis, et al.. (2018). Primary Hepatic Leiomyosarcoma: a Case Report and Review of the Literature. Acta Medica (Hradec Kralove Czech Republic). 61(4). 153–157. 9 indexed citations
12.
Garmpis, Nikolaos, Christos Damaskos, Anna Garmpi, et al.. (2017). Targeting Histone Deacetylases in Malignant Melanoma: A Future Therapeutic Agent or Just Great Expectations?. Anticancer Research. 37(10). 5355–5362. 41 indexed citations
13.
Papapanagiotou, Ioannis, Dimitra Koulocheri, Vasileios Kalles, et al.. (2017). Margin-free excision of small solid breast carcinomas using the Intact Breast Lesion Excision System®: is it feasible?. Breast Cancer. 25(2). 134–140. 7 indexed citations
14.
Damaskos, Christos, Nikolaos Garmpis, Anna Garmpi, et al.. (2017). Angiomyolipoma of the Liver: A Rare Benign Tumor Treated with a Laparoscopic Approach for the First Time. In Vivo. 31(6). 1169–1173. 10 indexed citations
15.
Cserni, Gábor, Giuseppe Floris, Nektarios Koufopoulos, et al.. (2017). Invasive lobular carcinoma with extracellular mucin production—a novel pattern of lobular carcinomas of the breast. Clinico-pathological description of eight cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 471(1). 3–12. 31 indexed citations
16.
Patsouris, Efstratios, et al.. (2015). Bax and Bak expression in cervical smears of women with low-and high-risk HPV types: A study of 120 cases. Journal of Cytology. 32(4). 223–223. 9 indexed citations
17.
Theodoropoulos, George, Ioannis Papapanagiotou, Maria Matiatou, et al.. (2012). Complications of percutaneous stereotactic vacuum assisted breast biopsy system utilizing radio frequency. European Journal of Radiology. 82(4). 623–626. 18 indexed citations
18.
Spyrou, George M., Ioannis Andreadis, Dimitra Koulocheri, et al.. (2010). Downgrading BIRADS 3 to BIRADS 2 category using a computer-aided microcalcification analysis and risk assessment system for early breast cancer. Computers in Biology and Medicine. 40(11-12). 853–859. 8 indexed citations
19.
Zagouri, Flora, Theodoros Ν. Sergentanis, Afroditi Nonni, et al.. (2007). Vacuum-assisted breast biopsy: The value and limitations of cores with microcalcifications. Pathology - Research and Practice. 203(8). 563–566. 10 indexed citations
20.
Zagouri, Flora, Theodoros Ν. Sergentanis, Afroditi Nonni, et al.. (2007). Secondary breast lymphoma diagnosed by vacuum-assisted breast biopsy: a case report. Journal of Medical Case Reports. 1(1). 113–113. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026